Nuo Therapeutics, Inc.

Biotechnology • Healthcare • Houston, TX, United States • AURX (OQB)

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Roth Capital Initiates Coverage of Nuo Therapeutics (AURX) with Buy Recommendation - Nasdaq

Nasdaq • Dec 16

Nuo Therapeutics Reports Key Governance Decisions at Meeting - TipRanks

TipRanks • Dec 16

Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewswire

GlobeNewswire • Apr 29

Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewswire

GlobeNewswire • Apr 17

Charles E. Sheedy buys $93,750 of Nuo Therapeutics stock By Investing.com - Investing.com UK

Investing.com UK • Sep 20

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Nuo Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Nuo Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Nuo Therapeutics, Inc. have?

Nuo Therapeutics, Inc. has approximately 9 employees.

What industry is Nuo Therapeutics, Inc. in?

Nuo Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Nuo Therapeutics, Inc. a publicly traded company?

Yes, Nuo Therapeutics, Inc. is publicly traded under the ticker symbol AURX on the OQB. The company has a market capitalization of approximately $0.10 billion.

Where is Nuo Therapeutics, Inc. headquartered?

Nuo Therapeutics, Inc. is headquartered in Houston, TX, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.